G673-0570 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide

G673-0570 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide
G673-0570 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G673-0570
N-(2H-1,3-benzodioxol-5-yl)-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G673-0570

Molecular Formula

C26H28N4O5 (C26 H28 N4 O5)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]acetamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-2-[6-oxo-3-(pyrrolidine-1-carbonyl)-5H6H6aH7H8H9H10H-pyrido[12-a]quinoxalin-5-yl]acetamide

SMILES

O=C(CN1c(cc(cc2)C(N3CCCC3)=O)c2N(CCCC2)C2C1=O)Nc(cc1)cc2c1OCO2

InChI

InChI=1S/C26H28N4O5/c31-24(27-18-7-9-22-23(14-18)35-16-34-22)15-30-21-13-17(25(32)28-10-3-4-11-28)6-8-19(21)29-12-2-1-5-20(29)26(30)33/h6-9,13-14,20H,1-5,10-12,15-16H2,(H,27,31)/t20-/m0/s1

InChI Key

SHULIGSXAALPAB-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27150537

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.435

Distribution Coefficient, logD

2.435

Water Solubility, LogSw

-3.01

Polar Surface Area

75.071

Acid Dissociation Constant (pKa)

11.21

Base Dissociation Constant (pKb)

2.47

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.30

G673-0570 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G673-0570 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G673-0570?
Check Price and Availability of G673-0570, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G673-0570 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G673-0570
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G673-0570
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G673-0570 available by request